arrow
T

Tomoaki Takata

Tottori University
H指数:18
被引数:1,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adoption of accelerated glucocorticoid tapering and its clinical consequences in ANCA-associated vasculitis: the J-CANVAS registry

采用加速糖皮质激素减量及其在ANCA相关性血管炎中的临床后果:J-CANVAS注册研究

2026-11-140
OAAI
Clinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts

基于集成聚类的ANCA相关性血管炎临床表型:来自两个日本队列的预后和治疗见解

2026-09-170
OAAI
Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS)

糖皮质激素-free临床缓解的预测因子:一项基于日本全国注册登记(J-CANVAS)的回顾性队列研究,研究对象为新诊断的显微镜下多血管炎和肉芽肿性多血管炎患者

2026-03-100
OAAI
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS

显微镜下多血管炎和肉芽肿性多血管炎中支气管扩张与严重感染的关系:来自J-CANVAS的研究

2026-02-110
PRE
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)

表型、血清型和数据驱动聚类揭示了ANCA相关性血管炎中异质性的互补维度:一项多中心日本队列(J-CANVAS)

2025-11-120
OAAI
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS

利妥昔单抗或静脉注射环磷酰胺与非用药在重症显微镜下多血管炎和肉芽肿性多血管炎患者中的真实世界有效性:一项J-CANVAS回顾性队列研究

2025-11-010
PRE
Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis

糖尿病和心脏疾病作为利妥昔单抗诱导的ANCA相关性血管炎急性血小板减少症的关键预测因子

2025-10-010
PRE
Myeloperoxidase-anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis
2025-10-010
PRE
C3 p.Asp1115Asn Variant-associated Atypical Hemolytic Uremic Syndrome with Spontaneous Remission Triggered by Influenza and COVID-19

C3 p.Asp1115Asn变异相关的不典型溶血尿毒症综合征,由流感及COVID-19触发自发缓解。国际医学杂志。11,6036-25

2025-09-011
OAAI
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study

不同利妥昔单抗方案治疗日本抗中性粒细胞胞浆抗体相关血管炎的缓解维持率及安全性:一项J-CANVAS研究

2025-01-110
OA